Amylin Pharmaceuticals (AMLN) rises 5.6% after activist investors Carl Icahn and Eastbourne...

|By:, SA News Editor

Amylin Pharmaceuticals (AMLN) rises 5.6% after activist investors Carl Icahn and Eastbourne Capital Management each gain at least one seat on the board. The dissidents got strong support from high-profile proxy advisory firms, which may have impacted the vote.